Immune Response Following COVID-19 Vaccination (mRNA or Non-mRNA) In Patients with Relapsing Multiple Sclerosis Treated with the Bruton's Tyrosine Kinase Inhibitor Evobrutinib: An Update
MULTIPLE SCLEROSIS JOURNAL（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要